ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Gujarat Kidney and Super Speciality (GKSL.NSE)
Gujarat Kidney and Super Speciality share price today, ATLAS forecast and fair value
Healthcare · Medical Care Facilities · National Stock Exchange of India · India
₹177.57▲ +0.63%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Gujarat Kidney and Super Speciality in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Gujarat Kidney and Super Speciality
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Gujarat Kidney and Super Speciality a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹165.75 and ₹189.96; in 9 out of 10, between ₹146.89 and ₹214.37. Estimated annual volatility is 41%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹14.8B
- Market cap (USD)
- $156M
- P/E ratio
- 73.9
- 52-week high
- ₹209.80
- 52-week low
- ₹98.36
- Revenue (12 months)
- ₹1.0B
- Operating margin
- 20.2%
- Net margin
- 15.7%
What this means
ATLAS does not publish a fair value for GKSL.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks GKSL.NSE has traded between ₹98.36 and ₹209.80. Today it is 15.4% below that high and 81% above its low.
On the business: net margin is 15.7%; it trades at 73.9 times earnings.
About the company
Gujarat Kidney and Super Speciality Limited is a healthcare company specializing in hospital services with a focus on super-specialty surgical solutions.
Want to see everything about Gujarat Kidney and Super Speciality?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Gujarat Kidney and Super Speciality do?
Gujarat Kidney and Super Speciality Limited is a healthcare company specializing in hospital services with a focus on super-specialty surgical solutions.
What is the chance GKSL.NSE goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, GKSL.NSE ends the month between ₹165.75 and ₹189.96.
How big is Gujarat Kidney and Super Speciality and what is its P/E ratio?
Gujarat Kidney and Super Speciality's market capitalization is ₹14.8B. Its price-to-earnings (P/E) ratio is 73.9: you pay ₹73.9 for each ₹1.00 of yearly earnings.
How volatile is GKSL.NSE?
ATLAS estimates annual volatility at 41%. In a typical month, half of the outcomes end between ₹165.75 and ₹189.96.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer